| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $59.0M | +7.8% | +81.0% |
| SG&A Expense | $14.8M | -6.0% | +11.8% |
| Operating Income | -$73.8M | -4.7% | -61.0% |
| Pre-tax Income | -$65.6M | -6.6% | -93.6% |
| Income Tax | $108K | -22.3% | +17.4% |
| Net Income | -$65.7M | -6.6% | -93.4% |
| EPS (Basic) | -$0.37 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $102.9M | -30.0% | -40.2% |
| Short-term Investments | $696.1M | +8.9% | -6.3% |
| Current Assets | $814.0M | +1.8% | -11.9% |
| Total Assets | $832.2M | +1.9% | -10.8% |
| Current Liabilities | $57.5M | +47.4% | +72.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$157.8M | — | — |
| Capital Expenditures | $2.1M | — | — |
| Investing Cash Flow | $33.7M | — | — |
| Financing Cash Flow | $57.5M | — | — |
| Free Cash Flow | -$159.9M | — | — |
| -2.8% |
| -85.0% |
| EPS (Diluted) | -$0.37 | -2.8% | -85.0% |
| $62.1M |
| +40.1% |
| +70.6% |
| Stockholders' Equity | $770.0M | -0.3% | -14.1% |